Weekly docetaxel and mitoxantrone prior to prostatectomy in patients with high risk localized prostate cancer

被引：0
|
作者：
Beer, TM
Garzotto, M
Lowe, BA
Ellis, WJ
Lange, PH
Montalto, MA
Higano, C
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1662
引用
收藏
页码：444 / 444
页数：1
相关论文
共 50 条
  • [1] Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate cancer
    Beer, TM
    Garzotto, M
    Lowe, BA
    Ellis, WJ
    Montalto, MA
    Lange, PH
    Higano, CS
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1306 - 1311
  • [2] Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients
    Font, Albert
    Mellado, Begona
    Aparicio, Luis A.
    Gallardo, Enrique
    Mel, Ramon
    Alcaraz, Antonio
    Areal, Juan
    Gomez Veiga, Francisco J.
    Hannaoui, Nahim
    Gascon, Pere
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 146 - 146
  • [3] Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer
    Garzotto, M
    Myrthue, A
    Higano, CS
    Beer, TM
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (03) : 254 - 259
  • [4] Adjuvant weekly docetaxel for high-risk prostate cancer patients after radical prostatectomy
    Kibel, AS
    Kattan, MW
    Picus, J
    Dreicer, R
    Klein, EA
    Wilding, G
    Jarrard, DF
    Roth, B
    Cookson, MS
    Pettylak, DP
    Chatta, G
    Nelson, JB
    Beer, TM
    Dipaola, R
    Partin, AI
    Rosenbaum, E
    Garrett, E
    Sugar, E
    Eisenberger, M
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 512 - 512
  • [5] Adjuvant weekly docetaxel for high-risk prostate cancer patients after Radical Prostatectomy
    Kibel, AS
    Picus, J
    Cookson, MS
    Roth, B
    Jarrard, DF
    Wilding, G
    Klein, EA
    Dreicer, R
    Nelson, JB
    Chatta, G
    Benson, MC
    Petrylak, DP
    DiPaola, R
    Beer, TM
    Diamond, J
    Partin, AW
    Eisenberger, MA
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 222 - 222
  • [6] Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer
    Febbo, PG
    Richie, JP
    George, DJ
    Loda, M
    Manola, J
    Shankar, S
    Barnes, AS
    Tempany, C
    Catalona, W
    Kantoff, PW
    Oh, WK
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5233 - 5240
  • [7] Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: A preliminary report
    Oh, WK
    George, DJ
    Kaufman, DS
    Moss, K
    Smith, MR
    Richie, JP
    Kantoff, PW
    [J]. SEMINARS IN ONCOLOGY, 2001, 28 (04) : 40 - 44
  • [8] Multicentre phase II trial of combination neoadjuvant hormone therapy and weekly docetaxel prior to radical prostatectomy in high risk localized prostate cancer (CUGG-PO1a).
    Gleave, ME
    Chi, KN
    Goldenberg, L
    Chin, J
    Winquist, E
    Klotz, L
    Saad, F
    Trachtenberg, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 415S - 415S
  • [9] Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial
    Kim, William Y.
    Whang, Young E.
    Pruthi, Raj S.
    Baggstrom, Maria Q.
    Rathmell, W. Kimryn
    Rosenman, Julian G.
    Wallen, Eric M.
    Goyal, Lav K.
    Grigson, Gayle
    Watkins, Catharine
    Godley, Paul A.
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (06) : 608 - 613
  • [10] Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study
    Baykal, Kadir
    Soydan, Hasan
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2007, 6 (02): : 33 - 35
12345